OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
6.37
-0.04 (-0.62%)
At close: Apr 28, 2026, 4:00 PM EDT
6.40
+0.03 (0.47%)
After-hours: Apr 28, 2026, 4:10 PM EDT

OptimizeRx Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for OptimizeRx stock have an average target of 16.67, with a low estimate of 10 and a high estimate of 24. The average target predicts an increase of 161.70% from the current stock price of 6.37.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $10 $16.67 $18 $24
Change +56.99% +161.70% +182.57% +276.77%
* Price targets were last updated on Mar 6, 2026.

Analyst Ratings

The average analyst rating for OptimizeRx stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '25Dec '25Jan '26Feb '26Mar '26Apr '26
Strong Buy 333344
Buy 111111
Hold 222211
Sell 000000
Strong Sell 000000
Total 666666

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Lake Street
Lake Street
Strong Buy
Maintains
$24$20
Strong Buy Maintains $24$20 +213.97% Mar 6, 2026
Roth Capital
Roth Capital
Strong Buy
Maintains
$32$18
Strong Buy Maintains $32$18 +182.57% Mar 6, 2026
B. Riley Securities
B. Riley Securities
Strong Buy
Reiterates
$28$11
Strong Buy Reiterates $28$11 +72.68% Mar 6, 2026
Stephens & Co.
Stephens & Co.
Hold
Maintains
$17$10
Hold Maintains $17$10 +56.99% Mar 6, 2026
Stifel
Stifel
Strong Buy
Maintains
$21$17
Strong Buy Maintains $21$17 +166.88% Mar 6, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
113.67M
from 109.43M
Increased by 3.88%
Revenue Next Year
123.15M
from 113.67M
Increased by 8.34%
EPS This Year
0.96
from 0.27
Increased by 255.74%
EPS Next Year
1.18
from 0.96
Increased by 22.39%
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
61.29M62.45M71.52M92.13M109.43M113.67M123.15M
Revenue Growth
41.51%1.89%14.53%28.81%18.78%3.88%8.34%
EPS
0.02-0.64-1.03-1.100.270.961.18
EPS Growth
-----255.74%22.39%
Forward PE
-----6.635.42
No. Analysts -----97
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20262027
High 119.8M 129.1M
Avg 113.7M 123.2M
Low 106.8M 115.9M

Revenue Growth

Revenue Growth 20262027
High
9.5%
13.5%
Avg
3.9%
8.3%
Low
-2.4%
2.0%

EPS Forecast

EPS 20262027
High 1.07 1.32
Avg 0.96 1.18
Low 0.75 1.09

EPS Growth

EPS Growth 20262027
High
296.7%
37.7%
Avg
255.7%
22.4%
Low
179.5%
13.3%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.